Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/216567
COMPARTIR / EXPORTAR:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorLópez-Mejías, Raquel-
dc.contributor.authorGenre, Fernanda-
dc.contributor.authorRemuzgo-Martínez, Sara-
dc.contributor.authorPulito-Cueto, Verónica-
dc.contributor.authorSevilla-Pérez, Belén-
dc.contributor.authorLlorca, J.-
dc.contributor.authorOrtego-Centeno, N.-
dc.contributor.authorMijares, V.-
dc.contributor.authorLera-Gómez, L.-
dc.contributor.authorLeonardo, María Teresa-
dc.contributor.authorPeñalba, Ana-
dc.contributor.authorCabero, M.J.-
dc.contributor.authorMartín-Penagos, Luis-
dc.contributor.authorMiranda-Filloy, J. A.-
dc.contributor.authorNavas Parejo, A.-
dc.contributor.authorSánchez Pérez, J.-
dc.contributor.authorÁrgila, Diego de-
dc.contributor.authorRubio, E.-
dc.contributor.authorLeón Luque, Manuel-
dc.contributor.authorBlanco-Madrigal, Juan María-
dc.contributor.authorGalíndez-Agirregoikoa, E.-
dc.contributor.authorMartín, J.-
dc.contributor.authorBlanco, R.-
dc.contributor.authorCastañeda, Santos-
dc.contributor.authorGonzález-Gay, M. A.-
dc.date.accessioned2020-07-14T08:10:33Z-
dc.date.available2020-07-14T08:10:33Z-
dc.date.issued2020-
dc.identifierissn: 0392-856X-
dc.identifiere-issn: 1593-098X-
dc.identifier.citationClinical and Experimental Rheumatology 38: 166- 170 (2020)-
dc.identifier.urihttp://hdl.handle.net/10261/216567-
dc.description.abstractOBJECTIVES: Cytokines signaling pathway genes represent a key component of the genetic network implicated in the pathogenesis of immunoglobulin-A vasculitis (IgAV), an inflammatory vascular pathology. Interleukin (IL)17A is described as a genetic risk locus for some autoimmune diseases, such as giant cell arteritis and spondyloarthritis. Accordingly, we aimed to determine the potential influence of IL17A on the pathogenesis of IgAV. METHODS: Five IL17A tag polymorphisms (rs4711998, rs8193036, rs3819024, rs2275913 and rs7747909), which cover the major variability of this gene, were genotyped in 360 Caucasian patients with IgAV and 1,003 sex and ethnically matched healthy controls using TaqMan probes. RESULTS: No statistically significant differences between patients with IgAV and healthy controls were observed when each IL17A genetic variant was analysed independently. Similarly, no statistically significant differences between patients with IgAV and healthy controls were found when the five IL17A polymorphisms were evaluated combined conforming haplotypes. In addition, there were no statistically significant differences in genotype, allele and haplotype frequencies of IL17A when patients with IgAV were stratified according to the age at disease onset or to the presence/absence of gastrointestinal or renal manifestations. CONCLUSIONS: Our results do not support an influence of IL17A on the pathogenesis of IgAV.-
dc.languageeng-
dc.publisherPacini Editore-
dc.rightsclosedAccess-
dc.titleInfluence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis-
dc.typeartículo-
dc.date.updated2020-07-14T08:10:34Z-
dc.relation.csic-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeartículo-
item.fulltextNo Fulltext-
Aparece en las colecciones: (IPBLN) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

Page view(s)

112
checked on 06-may-2024

Download(s)

14
checked on 06-may-2024

Google ScholarTM

Check


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.